Rivian is infamous for refusing to support CarPlay in its vehicles, and the CEO has doubled down on the decision in a recent ...

Rivian still has a long way to go in proving that it can be a big competitor in the EV space. An increase in competition in ...

Rivian's stock has been wrestling with long-standing investor debates over execution, cash burn and how the next chapter of ...

Rivian is making some big moves into autonomy and AI, but its success in EVs will likely come from selling cheaper vehicles.

During a recent podcast interview, Rivian CEO RJ Scaringe also claimed that Rivian owners rarely complain about the lack of ...

Rivian stock had been trending upward recently despite facing challenges. Here is a look at where the stock could be in a ...

AI Impact highlights Rivian’s autonomy strategy, hybrid AI gains in healthcare, AGI skepticism, exec moves and AI Impact ...

While AI updates are crucial for the stock, the firm noted that the company’s R2 SUV is the main reason for its bullish ...

At $6.26 billion, Medline is just the fifth US-listed firm to raise more than $5 billion in an IPO over the past decade, data ...

The shares are indicated at $33.50 each, versus the IPO price of $29. Medline, which counts Blackstone Inc., Carlyle Group ...

Medline shares surged in their trading debut Wednesday, after the medical supply company raised $6.26 billion in one of the biggest initial public offerings in recent years.

Discover why Polestar stock faces a sell rating amid ongoing losses, missed targets, and challenging EV demand.